- Monthly visits
- <5K
- Oct 2026
- Public revenue
- Undisclosed
- No public revenue evidence yet
- Entry price
- $18/mo
- Higher than 66% of peersNiche median $10.79/mo
- Launched
- 2y ago
- 2024-04-17 · Est.
Traffic
Marketing moves
Launches, search & content, referrals, promotionsLaunched on Product HuntLaunch
Software for Managing Billing and Quotations
Apr 17, 2024 · 2y agoLaunch page
Traffic sources
Oct 2026
Traffic breakdown
No traffic channel or country breakdown data for this website yet.
Search
Domain authority —Domain registered 2023-03-27
No search keyword data for this website yet.
Traffic data: Vaneform
Pricing
Gratuit
0 € /mois
1 société · 3 devis par mois · 3 factures par mois · Acomptes et paiements fractionnés · Clients et prospects, catalogue, tableau de bord · Envoi des documents par email
Pro
20 € /mois / 200 €/an
5 sociétés · 50 devis par mois · 50 factures par mois · Facturation électronique Factur-X (EN 16931) · Support par email
Trial: 15 jours d'essai Pro offerts, sans carte bancaire. · Observed 2026-11-08 · Pricing page
Entry price $18/mo, Higher than 66% of peers; “Invoicing & Payments” median is $10.79/mo.View pricing benchmark
Website snapshots
Indexed 2024-04-17
Key pages
Desktop & mobile archivegisalind.fr/ Snapshot 2026-11-08
Questions & evidence
- How much does Gisalind cost?
- Gratuit: 0 € /mois; Pro: 20 € /mois / 200 €/an. Observed 2026-11-08. Check the source for current billing terms, usage limits and taxes.Source
- How much website traffic does Gisalind get?
- Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
- What is Gisalind and what platforms does it support?
- Gisalind is catalogued under Invoicing & Payments: Gratuit pour démarrer, Pro quand vous grandissez. Supported platforms: Web.
Related products in this category
Finance / Invoicing & Payments
These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.